NiketaCShahMD

PubMed

• Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease.
  Lakshmanan Krishnamurti, Jingchen Liang, Zili He, Yanhong Deng, Vineetha R Nallagatla, Rohaum Hamidi, Aron Flagg, Niketa Shah> ;Blood Advances. 2024 Apr 23
• Mixed donor chimerism following stem cell transplantation for sickle cell disease.
  Niketa C Shah, Hemalatha G Rangarajan, Alexander Ngwube, Shalini Shenoy> ;Current Opinion in Hematology. 2023 Nov 1
• 1 citations
  Can defibrotide prophylaxis prevent sinusoidal obstruction syndrome following haematopoietic stem-cell transplantation?
  Niketa C Shah, Shalini Shenoy> ;The Lancet. Haematology. 2023 May 1
• 1 citations
  Role of abatacept in the prevention of graft--host disease: current perspectives.
  Alexander Ngwube, Hemalatha Rangarajan, Niketa Shah> ;Therapeutic Advances in Hematology. 2023 Jan 1
• Evidence-Based Minireview: In young children with severe sickle cell disease, do the benefits of HLA-identical sibling donor HCT outweigh the risks?
  Niketa Shah, Lakshmanan Krishnamurti> ;Hematology. American Society of Hematology. Education Program. 2021 Dec 10
• 3 citations
  Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
  Hemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, Arunkumar Modi, Ann Haight, Christopher M McKinney, Daniel J McKeone, David K Buchbinder, Emmanuel Katsanis...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• 4 citations
  Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplan...
  Alexander Ngwube, Cara Franay, Niketa Shah> ;Pediatric Hematology and Oncology. 2022 Aug 1
• 2 citations
  Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.
  Niketa C Shah, Sweta Bhoopatiraju, Allistair Abraham, Eric Anderson, Martin Andreansky, Monica Bhatia, Sonali Chaudhury, Geoff D E Cuvelier, Kamar Godder, Michael Grim...> ;Transplantation and Cellular Therapy. 2022 Mar 1
• 1 citations
  Bone marrow transplant using fludarabine-based reduced intensity conditioning regimen with in vivo T cell depletion in patients with Fanconi anemia.
  Lev Gorfinkel, Carolyn Demsky, Farzana Pashankar, Gary M. Kupfer, Niketa Shah> ;Pediatric Transplantation. 2021 Mar 23
• 31 citations
  Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease
  Alexander Ngwube, Niketa Shah, Kamar Godder, David A. Jacobsohn, Monica L. Hulbert, Shalini Shenoy> ;Blood Advances. 2020 Aug 25
• 3 citations
  Gene therapy in sickle cell disease: Possible utility and impact.
  Susanna A Curtis, Niketa Shah> ;Cleveland Clinic Journal of Medicine. 2020 Jan 1
• CAR-T cell manufacture: snatching victory when defeat is looming
  Lohith Gowda, Niketa Shah> ;Transfusion. 2018 Jun 1
• 33 citations
  Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
  Niketa Shah, Ali Al-Ahmari, Arwa Al-Yamani, L. Lee Dupuis, Derek Stephens, Johann Hitzler> ;Pediatric Blood & Cancer. 2009 Jan 1
• 10 citations
  Late-appearing Philadelphia chromosome in childhood acute myeloid leukemia.
  Niketa Shah, Michael T. Leaker, Ikuko Teshima, Sylvain Baruchel, Mohamed Abdelhaleem, Charles Ye> ;Pediatric Blood & Cancer. 2008 May 1
• 35 citations
  Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.
  Ali Al-Ahmari, Niketa Shah, Lillian Sung, Alvin Zipursky, Johann Hitzler> ;British Journal of Haematology. 2006 Jun 1
• A 16-Year-Old Girl With Hypochromic Microcytic Anemia
  Charles Ye, Niketa Shah, Vernon D. Edwards, Melanie Kirby-Allen> ;Archives of Pathology & Laboratory Medicine. 2005 Nov 1
• Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
  Niss O, Lorsbach RB, Berger M, Chonat S, McLemore M, Buchbinder D, McCavit T, Shaffer LG, Simpson J, Schwartz JH, Meznarich J, Emberesh M, Seu KG, Zhang W, Kalfa TA, C...> ;Blood cells, molecules & diseases. 2020-12-24
• 5 citations
  Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
  Marie-Claude Pelland-Marcotte, Nour Amiri, Maria L Avila, Leonardo R Brandão> ;The Cochrane Database of Systematic Reviews. 2020 Jun 18
• 11 citations
  Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant.
  Vanessa A Fabrizio, Nancy A. Kernan, Farid Boulad, Maria Cancio, Jennifer Allen, Meghan A. Higman, Steven P. Margossian, Audrey Mauguen, Susan E. Prockop, Andromachi S...> ;Bone Marrow Transplantation. 2020 May 10
• 8 citations
  Reduced-toxicity allogeneic hematopoietic stem cell transplantation in congenital sideroblastic anemia.
  Min Hee Kim, Sanjay Shah, Sylvia S. Bottomley, Niketa Shah> ;Clinical Case Reports. 2018 Aug 1
• 14 citations
  Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant R...
  Michael J. Burke, Michael R. Verneris, Jennifer Le Rademacher, Wensheng He, Hisham Abdel-Azim, Allistair Abraham, Jeffery J. Auletta, Mouhab Ayas, Valerie I. Brown, Mi...> ;Biology of Blood and Marrow Transplantation. 2015 Dec 1
• 1 citations
  Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
  Leonardo R Brandão, Niketa Shah, Prakeshkumar S Shah> ;The Cochrane Database of Systematic Reviews. 2014 Mar 10
• 3 citations
  Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
  Prakeshkumar S Shah, Niketa Shah> ;The Cochrane Database of Systematic Reviews. 2014 Feb 25
• Persistent human rhinovirus type C infection of the lower respiratory tract in a pediatric cord blood transplant recipient.
  Pathak, A. K., Adams, R. H., Shah, N. C., Gustin, K. E.> ;Bone Marrow Transplant. 2013 May
• 8 citations
  Diffuse intrinsic brainstem tumors in neonates : Report of 2 cases
  Niketa C Shah, Amitava Ray, Ute Bartels, James T. Rutka, Eric Bouffet, James M. Drake, Cynthia Hawkins, Annie Huang> ;Journal of Neurosurgery. Pediatrics. 2008 May 1
• Join now to see all

Abstracts/Posters

• Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease
  Niketa C. Shah, MD , Sweta Bhoopatiraju , Allistair Abraham, MD , Eric Jon Anderson, MD , Martin Andreansky, MD , Monica Bhatia, MD , Sonali Chaudhury, MD , Geoff D.E...., American Society of Hematology, Virtual, 12/5/2020
• Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
  Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)
  Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019